Aston Health at the international conference on personalized oncology

Publication date: 12 october 2017

On October 12, 2017 the First Moscow State Medical University hosted an International Conference on Personalized Oncology. The Conference provided a platform for medical researchers and experts in the field to discuss the challenges and prospects for personalized cancer care.

One of the panel sessions was devoted to the current clinical approaches in personalized cancer care where participants discussed the findings of the report "Pathomorphology: New Opportunities in Personalized Cancer Care: Diagnostic and Predictive Protocols" prepared by Evgeniya Kogan, Head of Morbid Anatomy Department at the First Moscow State Medical University and Sofia Demura, Medical Director, Aston Health. The conference was attended by a number of the leading experts from various international cancer research centers, including:

• The Institute of Personalized Cancer Care and Genomic Medicine Department, University of Texas, Houston, USA.
• Mechanobiology and Microfluidics Laboratory and the Center for Emergent Behaviors of Integrated Cellular Systems, MIT, Cambridge, Massachusetts, USA.
• Department of Laboratory Medicine and Pathology and HTA Department, Mayo Clinic's Center for Personalized Medicine, Rochester, Minnesota, USA.
• Skolkovo Institute of Science and Technology, Moscow Region; Institute of Physics and Technology, Moscow Region; Institute of Energy Problems of Chemical Physics, Moscow.
• Seoul National University, College of Medicine, Seoul, South Korea.